In Testimony Before House Subcommittee, Grealy Also Tells Congress it Must Scrutinize Impact of Physician Payment “Sunshine Act” on Health Innovation
WASHINGTON – In testimony before the House Energy and Commerce health subcommittee today, Healthcare Leadership Council president Mary R. Grealy testified that, in order to advance health system improvements and medical research, federal health data should no longer be denied to commercial entities.
Ms. Grealy’s testimony came in a subcommittee hearing on the Energy and Commerce “21st Century Cures” initiative and existing barriers to developing and communicating medical evidence. The Healthcare Leadership Council is a coalition of chief executives of the nation’s leading healthcare companies and organizations. An HLC member CEO, Michael Mussallem of Edwards Lifesciences, also testified at the hearing.
More Details »